Medical specialists from Belgium tagged as investigators in clinical trials studying Carcinoma, Non-Small-Cell Lung
Total 61 results
-
Anne Sibille, MDSeen in:
- Liège, CHU Liège- Sart Tilman
Trials:- NCT03970746 (Principal Investigator)
Conditions: -
Annelies JanssensSeen in:
- Antwerpen, Edegem, Antwerp University Hospital
- Edegem, Universitair Ziekenhuis Antwerpen
Trials:- NCT04819100 (Principal Investigator)
Conditions: -
Bart Vandekerckhove, MD, PhDSeen in:
- Ghent, Ghent University Hospital
Trials:- NCT04078269 (Sub-Investigator)
Conditions: -
Benoit Colinet, MDSeen in:
- Charleroi, Grand Hopital de Charleroi
Trials:- NCT03970746 (Principal Investigator)
Conditions: -
Charlotte De BondtSeen in:
- Edegem, Antwerp University Hospital (UZA)
Trials:- NCT04447118 (Principal Investigator)
Conditions: -
Chris Burtin, PhDSeen in:
- Limburg, Hasselt, Hasselt University
Trials:- NCT06057766 (Principal Investigator)
Conditions: -
Christel Oyen, RNSeen in:
- Leuven, UZLeuven
Trials:- NCT04216121 (Sub-Investigator)
-
Christine Collen, MDSeen in:
- Brussels, Jette, UZ Brussel Radiotherapie dienst
Trials:- NCT02224547 (Principal Investigator)
Conditions: -
christophe DoomsSeen in:
- Leuven, U.Z. Leuven - Campus Gasthuisberg
- Leuven, University Hospital (UZ) Leuven
- Leuven, University Hospitals KU Leuven
- Vlaams-Brabant, Leuven, UZ Leuven
Trials:- NCT02834884 (Principal Investigator)
- NCT02906280 (Principal Investigator)
- NCT04447118 (Principal Investigator)
- NCT06119581 (Principal Investigator)
-
Daniella GALDERMANSSeen in:
- Antwerpen, Antwerp, ZNA Middelheim
Trials:- NCT04194944 (Principal Investigator)
Conditions: -
Dieter Stevens, MDSeen in:
- Oost-Vlaanderen, Ghent, Ghent University Hospital
Trials:- NCT06057766 (Principal Investigator)
Conditions: -
Elke GovaertsSeen in:
- Gent, Algemeen Ziekenhuis Sint-Lucas
Trials:- NCT05403385 (Principal Investigator)
Conditions: -
Els Wauters, DrSeen in:
- Leuven, UZLeuven
- Leuven, University Hospitals KU Leuven
Trials:- NCT03970746 (Principal Investigator)
- NCT04216121 (Sub-Investigator)
-
Eva Arents, MscSeen in:
- Oost-Vlaanderen, Ghent, Ghent University Hospital
Trials:- NCT06057766 (Sub-Investigator)
Conditions: -
Frank AboubakarSeen in:
- Bruxelles-Capitale, Région De, Brussels, Cliniques Universitaires Saint-Luc
Trials:- NCT04819100 (Principal Investigator)
Conditions: -
Frederique Bustin, MDSeen in:
- Liège, C. H. R. de la Citadelle - 2103
Trials:- NCT05671510 (Principal Investigator)
Conditions: -
Heleen Demeyer, PhDSeen in:
- Oost-Vlaanderen, Ghent, Ghent University Hospital
Trials:- NCT06057766 (Principal Investigator)
Conditions: -
Ingel DemedtsSeen in:
- Roeselaere, GSK Investigational Site
- Roeselare, AZ Delta
- West-Vlaanderen, Roeselare, AZ Delta
- West-Vlaanderen, Roeselare, AZ Delta vzw
Trials:- NCT04475939 (Principal Investigator)
- NCT05376891 (Principal Investigator)
- NCT04819100 (Principal Investigator)
- NCT05403385 (Principal Investigator)
- NCT06057766 (Principal Investigator)
-
Ionela Bold, MDSeen in:
- Charleroi, Department of Pneumology CHU Charleroi
Trials:- NCT04465942 (Principal Investigator)
Conditions: -
Jacques De Grève, MD PhDSeen in:
- Jette, AZ VUB
Trials:- NCT00339586 (Principal Investigator)
-
Jean-Charles GoeminneSeen in:
- Namur, CHU Site Sainte-Elisabeth-UCL Namur
- Namur, CHU UCL Namur
- Namur, CHU UCL Namur/Site Sainte Elisabeth
- Namur, Trial Office
Trials:- NCT04819100 (Principal Investigator)
- NCT05288166 (Principal Investigator)
- NCT02834884 (Principal Investigator)
- NCT05403385 (Principal Investigator)
Conditions:- Carcinoma, Non-Small-Cell Lung;
- Urogenital Neoplasms;
- Prostatic Neoplasms;
- Neoplasm Metastasis;
- Enzyme Inhibitors;
- Antineoplastic Agents;
- Hormones;
- Physiological Effects of Drugs;
- Antineoplastic Agents, Hormonal;
- Androgens;
- Hormones, Hormone Substitutes, and Hormone Antagonists;
- Abiraterone Acetate;
- Steroid Synthesis Inhibitors;
- Cytochrome P-450;
- Prednisone;
- Prednisolone;
- Cyclin-Dependent Kinase 4;
- Cyclin-Dependent Kinase 6;
- All Tumor Types;
- Metastatic NSCLC;
- Stage III NSCLC
-
Jo Raskin, MDSeen in:
- Edegem, Universitair Ziekenhuis Antwerpen
Trials:- NCT04127110 (Principal Investigator)
Conditions: -
Johan VansteenkisteSeen in:
- Leuven, GSK Investigational Site
- Leuven, UZLeuven
Trials:- NCT04475939 (Principal Investigator)
- NCT04216121 (Sub-Investigator)
-
Karin Pat, MDSeen in:
- Limburg, Hasselt, Jessa Ziekenhuis
Trials:- NCT06057766 (Principal Investigator)
Conditions: -
Katrien GhysenSeen in:
- West-Vlaanderen, Kortrijk, AZ Groeninge Campus Kennedylaan
Trials:- NCT06119581 (Principal Investigator)
Conditions: -
Kim De MuynckSeen in:
- Antwerpen, Antwerp, ZNA Middelheim
Trials:- NCT06119581 (Principal Investigator)
Conditions:
Clinical Trials on Carcinoma, Non-Small-Cell Lung
-
Sidney Kimmel Cancer Center at Thomas Jefferson...Bristol-Myers SquibbCompletedStage IIIA Non-Small Cell Lung Cancer | Stage IIA Non-Small Cell Lung Carcinoma | Stage IIB Non-Small Cell Lung Carcinoma | Stage I Non-Small Cell Lung Cancer | Stage II Non-Small Cell Lung Cancer | Stage IA Non-Small Cell Lung Carcinoma | Stage IB Non-Small Cell Lung Carcinoma | Non-Squamous Non-Small...United States
-
National Cancer Institute (NCI)CompletedStage IIIA Non-Small Cell Lung Cancer | Recurrent Non-Small Cell Lung Carcinoma | Stage IV Non-Small Cell Lung Cancer | Stage IIA Non-Small Cell Lung Carcinoma | Stage IIB Non-Small Cell Lung Carcinoma | Stage IB Non-Small Cell Lung CarcinomaUnited States
-
National Cancer Institute (NCI)TerminatedStage IIIA Non-Small Cell Lung Cancer | Stage IIA Non-Small Cell Lung Carcinoma | Stage IIB Non-Small Cell Lung Carcinoma | Stage IA Non-Small Cell Lung Carcinoma | Stage IB Non-Small Cell Lung CarcinomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingStage IB Lung Non-Small Cell Carcinoma AJCC v7 | Stage IIA Lung Non-Small Cell Carcinoma AJCC v7 | Stage IIB Lung Non-Small Cell Carcinoma AJCC v7 | Stage IIIA Lung Non-Small Cell Cancer AJCC v7 | Recurrent Lung Non-Small Cell Carcinoma | Stage IIIB Lung Non-Small Cell Cancer AJCC v7 | Stage IA...United States
-
National Cancer Institute (NCI)Active, not recruitingLung Non-Squamous Non-Small Cell Carcinoma | Stage IB Lung Non-Small Cell Carcinoma AJCC v7 | Stage II Lung Non-Small Cell Cancer AJCC v7 | Stage IIA Lung Non-Small Cell Carcinoma AJCC v7 | Stage IIB Lung Non-Small Cell Carcinoma AJCC v7 | Stage IIIA Lung Non-Small Cell Cancer AJCC v7United States, Puerto Rico
-
National Cancer Institute (NCI)TerminatedStage IIIA Non-Small Cell Lung Cancer | Stage IIA Non-Small Cell Lung Carcinoma | Stage IIB Non-Small Cell Lung Carcinoma | Stage IA Non-Small Cell Lung Carcinoma | Stage IB Non-Small Cell Lung CarcinomaUnited States
-
M.D. Anderson Cancer CenterActive, not recruitingStage IB Lung Non-Small Cell Carcinoma AJCC v7 | Stage II Lung Non-Small Cell Cancer AJCC v7 | Stage IIA Lung Non-Small Cell Carcinoma AJCC v7 | Stage IIB Lung Non-Small Cell Carcinoma AJCC v7 | Stage IIIA Lung Non-Small Cell Cancer AJCC v7 | Stage I Lung Non-Small Cell Cancer AJCC v7 | Stage...United States
-
National Cancer Institute (NCI)Active, not recruitingStage IIIA Lung Non-Small Cell Cancer AJCC v7 | Advanced Lung Non-Squamous Non-Small Cell Carcinoma | Metastatic Lung Non-Squamous Non-Small Cell Carcinoma | Stage IIIB Lung Non-Small Cell Cancer AJCC v7 | Stage IV Lung Non-Small Cell Cancer AJCC v7 | Stage III Lung Non-Small Cell Cancer AJCC...United States
-
University of Southern CaliforniaNational Cancer Institute (NCI); Society of Thoracic RadiologyActive, not recruitingStage IIA Non-Small Cell Lung Carcinoma | Stage IIB Non-Small Cell Lung Carcinoma | Stage IA Non-Small Cell Lung Carcinoma | Stage IB Non-Small Cell Lung CarcinomaUnited States
-
National Cancer Institute (NCI)CompletedStage IIIA Non-Small Cell Lung Cancer | Stage IIIB Non-Small Cell Lung Cancer | Stage IIA Non-Small Cell Lung Carcinoma | Stage IIB Non-Small Cell Lung Carcinoma | Stage IA Non-Small Cell Lung Carcinoma | Stage IB Non-Small Cell Lung CarcinomaUnited States